4.4 Article

Chronic Kidney Disease and CHADS2 Score Independently Predict Cardiovascular Events and Mortality in Patients With Nonvalvular Atrial Fibrillation

期刊

AMERICAN JOURNAL OF CARDIOLOGY
卷 107, 期 6, 页码 912-916

出版社

EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjcard.2010.10.074

关键词

-

向作者/读者索取更多资源

Chronic kidney disease is a risk factor for cardiovascular events, but how it relates to the prognosis associated with clinical risk factors for thromboembolism in patients with nonvalvular atrial fibrillation (AF) is not well known. Estimated glomerular filtration rate (eGFR), score for congestive heart failure, hypertension, age >= 75 years, diabetes. mellitus, and stroke/transient ischemic attack (CHADS(2)), and clinical outcomes of cardiovascular events were determined in 387 patients with nonvalvular AF (mean age 66 years, 289 men, mean follow-up 5.6 +/- 3.2 years). Decreased eGFR (< 60 ml/min/1.73 m(2)) combined with CHADS(2) score was associated with higher all-cause (12.9% vs 1.4% per year, hazard ratio [HR] 6.9, p < 0.001) and cardiovascular (6.5% vs 0.2% per year, HR 29.7, p < 0.001) mortalities compared to preserved eGFR (>= 60 ml/min/1.73 m(2)) combined with CHADS(2) score < 2. This was also true for rates of cardiac events (cardiac death, nonfatal myocardial infarction, or hospitalization for worsening of heart failure, 10.4% vs 1.3% per year, HR 8.9, p < 0.001), ischemic stroke (3.6% vs 0.2% per year, HR 11.0, p < 0.001), and cardiovascular events (cardiac events and ischemic stroke, 13.6% vs 1.5% per year, HR 8.3, p < 0.001). On multivariate analysis, CHADS(2) score decreased eGFR, and male gender independently predicted all-cause mortality. In conclusion, combined eGFR and CHADS(2) score could be an independent powerful predictor of cardiovascular events and mortality in patients with nonvalvular AF. Long-term mortality, cardiac events, and stroke risk were > 8 times higher when decreased eGFR (<60 ml/min/1.73 m(2)) was present with higher CHADS(2) score (>= 2). (C) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;107:912-916)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据